DEEPER
BehavioralA transcultural scientific digital platform (Rehab companion, Inselspital, University Hospital of Bern) for content delivery, feedback and digital biomarker monitoring will be made available.
NCT Number: NCT07252856
Multicenter Prospective Controlled Randomized Trial, open-label, in patients with atherosclerotic cardiovascular disease (ASCVD) (acute coronary syndrome or chronic coronary syndrome and ischemic heart failure) and an approved indication for cardiac rehabilitation (CR). Patients completing phase II CR will be randomized 1:1 to usual Phase-III care (standard care) versus standard care plus the Digitally-Enhanced Extended PrEvention & Rehabilitation (DEEPER) package (intervention). Primary outcome is 6-month change in composite Life's Crucial 9 (LC9) (LE8 + PHQ-9).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
KU Leuven, Kaatje Goetschalckx, KU Leuven, Leuven, Belgium
Multicenter Prospective Controlled Randomized Trial, open-label, in patients with atherosclerotic cardiovascular disease (ASCVD) (acute coronary syndrome or chronic coronary syndrome and ischemic heart failure) and an approved indication for cardiac rehabilitation (CR). Patients completing phase II CR will be randomized 1:1 to usual Phase-III care (standard care) versus standard care plus the Digitally-Enhanced Extended PrEvention & Rehabilitation (DEEPER) package (intervention). Primary outcome is 6-month change in composite Life's Crucial 9 (LE9) (LE8 + PHQ-9). Intervention (DEEPER) will include informative modules (patient will choose among graphic medicine, video or interactive messaging) that will be delivered every two weeks via secure digital platform (or booklet if offline); monthly motivational messages; moderated peer-support forum with leaderboard; remote wearable step/sleep upload with personalized content assignment and feedback, linked to the hospital interactive digital platform (Rehab companion).
Patients will be encouraged to have their own device to be adopted as lifelong maintenance. Nevertheless, centres will provide a smartwatch (fitbit) to all the patients enrolled in the trial as incentive for study participation and to uniformly collect study outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A transcultural scientific digital platform (Rehab companion, Inselspital, University Hospital of Bern) for content delivery, feedback and digital biomarker monitoring will be made available.
Time frame: 6-month change
LC9 is defined by the American Heart Association's Life's Essential 8 (LE8), complemented by the Patient Health Questionnaire (PHQ-9), collectively referred to as "LC9 [blood pressure, non-high-density lipoprotein cholesterol (HDL), diet questionnaire, physical activity, smoking habits, sleep health, body mass index (BMI), hemoglobin A1c (HbA1c, %), PHQ9 from questionnaire).
Time frame: 6-month change
Reported as differences in the absolute value among the two groups (median and (IQR)
Time frame: 6 months
defined as a composite of death of any cause, myocardial infarction, unplanned revascularization, rehospitalization for any cause, stroke, considered in a hierarchical way and as single endpoint
Time frame: 1 year
defined as a composite of death of any cause, myocardial infarction, unplanned revascularization, rehospitalization for any cause, stroke, considered in a hierarchical way and as single endpoint
Time frame: Changes between baseline and 6-month follow-up
anxiety score; Seven-item questionnaire that assesses the severity of anxiety symptoms over the past two weeks, with a total score ranging from 0 to 21
Time frame: Changes between baseline and 6-month follow-up
depression score; The PHQ-9 score ranges from 0 to 27. Scores between 5 and 9 indicate the presence of subthreshold depression.
Time frame: Changes between baseline and 6-month follow-up
distance achieved in 6-minute walking test
Time frame: Changes between baseline and 6-month follow-up
cardiopulmonary test (CPET)
Time frame: Changes between baseline and 6-month follow-up
number of times the patient stands in 30 seconds
Time frame: Changes between baseline and 6-month follow-up
maximum voluntary muscle strength measured by dynamometer
Time frame: Changes between baseline and 6-month follow-up
amount of steps during the day
Time frame: Changes between baseline and 6-month follow-up
Waist circumference in cm
Time frame: Changes between baseline and 6-month follow-up
Maximum power measured by dynamometer; difference in the absolute value among the two groups
Time frame: 6 months
Compliance with study treatment defined as number (percentage) of patients who will attend the sessions provided and will complete the study.
Time frame: 6 months
Direct costs of the two pathways, estimated using Activity Based Costing and financial sustainability measured with a budget impact analysis (BIA). Results reported as mean difference and standard deviation (SD) between groups.
Cost per patient and cost-effectiveness ratio will be calculated per group of treatment.
Time frame: 6 months
Responses to SUTAQ-based questionnaire administered to patients involved in the study, analyzed through a seven items scale scoring. Results reported as mean, p-value and linear regression models for enhanced care, increased accessibility, privacy and discomfort, care personnel concerns, telerehabilitation as substitution and satisfaction.
Time frame: 6 months
Perceptions reported by the patients, measured with a seven item Likert scale structured questionnaire based on the EUnetHTA Core Model dimensions, comparing standard care versus DEEPER package (mean and p-value)
Time frame: 6 months
Analysis of the indirect and out of pocket costs as average value in case of standard care and DEEPER package, to define the social costs related to the interventions.
Time frame: 6 months
Musculo-skeletal injuries (requiring medical attention) and Arrhythmias (atrial fibrillation, supraventricular tachycardia, ventricular tachycardia) requiring medical attention and an emergency room or ambulatory visit.
Contact information is provided by the study sponsor or research team.
Anastasia Toccafondi
CONTACT
Nuccia Morici, MD
CONTACT
Fondazione Don Carlo Gnocchi ETS
Other
CrOss-cultural Model for Postdischarge Assistance and Sustainable Digital Solutions in Phase III Cardiac Rehabilitation: a Randomized Controlled Trial
Acronym: COMPASS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06699056
Arrhythmias, Cardiac, Atrial Enlargement
Orange, California, United States
View Trial DetailsNCT06271577
Cardiovascular Diseases, Heart Attack
Rochester, Minnesota, United States
View Trial DetailsNCT03854071
Arterial Occlusive Diseases, Arteriosclerosis
Sheffield, England, United Kingdom
View Trial DetailsNCT02973633
Cardiomegaly, Cardiovascular Diseases
Charlestown, Massachusetts, United States
View Trial Details